home / stock / pki / pki news


PKI News and Press, PerkinElmer Inc. From 05/17/21

Stock Information

Company Name: PerkinElmer Inc.
Stock Symbol: PKI
Market: NYSE
Website: perkinelmer.com

Menu

PKI PKI Quote PKI Short PKI News PKI Articles PKI Message Board
Get PKI Alerts

News, Short Squeeze, Breakout and More Instantly...

PKI - When the Price of Perkinelmer #PKI Talks, People Listen

This is not EF Hutton, but it could be more #powerful.  A picture speaks a thousand words, they say, and the #priceaction of Perkinelmer (NYSE: PKI) tells an important story.  The movement tells us where investors perceive value, or the lack of it, and if we pay attention we c...

PKI - Wall Street Breakfast: Musk Keeps Roiling Crypto

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Musk keeps roiling cryptoCryptocurrency is still under pressure this morning following tweets from Tesla (TSLA) CEO Elon Musk that rattled the market over ...

PKI - PerkinElmer to acquire U.K.-based in-vitro diagnostics company for $155M

PerkinElmer (PKI) and Immunodiagnostic Systems Holdings ((IDS)) have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for ~$155M (£110M).The transaction has a total enterprise value of ~$124M (£88M) and is expected to close early...

PKI - PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approx...

PKI - PerkinElmer to acquire Nexcelom for $260 Million

PerkinElmer (PKI) has agreed to acquire private-held Nexcelom Bioscience for $260M in cash.Headquartered in Lawrence, Massachusetts Nexcelom is a developer and marketer of image cytometry products for cell analysis.The company with ~130 employees, has operations in the U.S., the UK, and China...

PKI - PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing PerkinElmer, Inc . (NYSE: PKI) is pleased to announce it has entered into an agreement to acquir...

PKI - Oxford Immunotec's T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer, announced that its T-SPOT ® . COVID test will be used for T cell testing in the COV-AD ( COV ID infection in patie...

PKI - How to Improve The Timing of Investment Decisions in Perkinelmer #PKI

Some people say that #timing does not matter, but it does.  If you were to #buyandhold Perkinelmer (NYSE: PKI) at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling.  Over time, Stock Traders Daily has found a way...

PKI - PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q1 2021 Earnings Call May 4, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript

PKI - PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q1 2021 Results - Earnings Call Transcript

PerkinElmer, Inc. (PKI) Q1 2021 Results Earnings Conference Call May 04, 2021, 5:00 pm ET Company Participants Bryan Kipp - Vice President of Investor Relations Prahlad Singh - President, Chief Executive Officer Jamey Mock - Senior Vice President, Chief Financial Officer Conference Call Parti...

Previous 10 Next 10